Documentos relacionados

1. Comparison of the effectiveness four years after Homo/Hetero prime-boost with 10 µg HP and 20 µg CHO recombinant hepatitis B vaccine at 1 and 6 months in maternal HBsAg-negative children.
2. Making innate sense of mRNA vaccine adjuvanticity.
3. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
4. Comparison of Synthetic Methods and Identification of Several Artificial Antigens of Deoxynivalenol.
5. Bad Liver and a Broken Heart: Hepatitis B in the Newborn.
6. Oral vaccination with recombinant Saccharomyces cerevisiae expressing Micropterus salmoides rhabdovirus G protein elicits protective immunity in largemouth bass.
7. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
8. Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine.
9. Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial.
10. Impact of a pharmacist-driven recombinant zoster vaccine administration program.